BioMed Research International

Uterine Fibroids: From Molecular Oncology to Reproduction

Publishing date
01 Apr 2018
Submission deadline
01 Dec 2017

Lead Editor

1Vito Fazzi Hospital, Lecce, Italy

2University of the Health Sciences, Bethesda, USA

3Brigham and Women’s Hospital, Boston, USA

4Carolinas Medical Center, Charlotte, USA

5State University, Moscow, Russia

6University of Salento, Lecce, Italy

7University of Pisa, Pisa, Italy

Uterine Fibroids: From Molecular Oncology to Reproduction


Smooth muscle tumors of the uterus encompass a large group of neoplasms representing the entire spectrum from benign to malignant. This includes benign uterine myomas, malignant leiomyosarcoma, and STUMPs (smooth muscle tumors of uncertain malignant potential).

Uterine myomas, also known as uterine fibroids or uterine leiomyomas, are the most common benign tumors of the genital organs of women of childbearing age. This disease has a negative impact on reproductive system, with a significant female morbidity and impairment of life quality. According to the literature, 40–60% of all hysterectomies are scheduled for fibroids, as the most common worldwide indication. The first who described uterine myomas was Matthew Baillie in 1793: they consist mainly of smooth muscle cells with different amounts of fibrous tissue, clearly surrounded by a neurofibrovascular network, the pseudocapsule, which enables their enucleation and enhances myometrial healing. Because of the wide spread of this disease, clinical interventions and costs associated with uterine myomas continue to escalate. For this reason, the interest and research in different myoma aspects, including transcription factors and gene targets involved in myoma development and new pharmacological and surgical treatments, have grown exponentially in the last several years.

Given this scenario, in this special issue we want to focus our attention on some aspects of uterine myoma pathophysiology including clinical features, animal models, molecular alterations, imaging characteristics, and therapeutic and surgical approaches. Understanding the many cellular processes that contribute to myoma formation could lead to targeted approaches to prevent and treat this disease. This can also shed light on the biological association between uterine myomas, STUMPs, and leiomyosarcoma. In fact, an additional level of complexity comes from the reliable differentiation between benign leiomyomas and uterine sarcomas. The diagnosis of uterine sarcoma is based upon histological examination, and uterine sarcomas are most commonly diagnosed following myomectomy or hysterectomy for presumed leiomyomas.

With so many questions, we invite investigators to contribute with original research articles as well as review articles that seek to address the contribution on myoma aspects.

Potential topics include but are not limited to the following:

  • Myoma and anatomical, biological, and genetic aspects
  • Diagnostic and prognostic significance of uncertain myoma biological aspects
  • Myoma and imaging
  • Myoma and fertility
  • Myoma and animal models
  • Myoma and surgical treatments
  • Myoma and surgical controversies
  • EMT signaling networks in the pathogenesis of leiomyosarcoma
  • Myoma and pharmacology, including targeting of EMT markers
  • Controversies on uterine myoma treatments


  • Special Issue
  • - Volume 2018
  • - Article ID 2804830
  • - Research Article

Submucous Fibroids, Fertility, and Possible Correlation to Pseudocapsule Thickness in Reproductive Surgery

Andrea Tinelli | Ioannis Kosmas | ... | Antonio Malvasi
  • Special Issue
  • - Volume 2018
  • - Article ID 6284875
  • - Editorial

Uterine Fibroids: From Molecular Oncology to Reproduction

Andrea Tinelli | William H. Catherino | ... | Antonio Giuseppe Naccarato
  • Special Issue
  • - Volume 2018
  • - Article ID 8429047
  • - Research Article

Risk Factors for the Completion of the Cold Loop Hysteroscopic Myomectomy in a One-Step Procedure: A Post Hoc Analysis

Ivan Mazzon | Alessandro Favilli | ... | Sandro Gerli
  • Special Issue
  • - Volume 2018
  • - Article ID 8367068
  • - Research Article

Does Uterine Fibroid Adversely Affect Obstetric Outcome of Pregnancy?

Hend S. Saleh | Hala E. Mowafy | ... | Eman M. Mahfouz
  • Special Issue
  • - Volume 2018
  • - Article ID 6832685
  • - Review Article

The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility

Jin-Jiao Li | Jacqueline P. W. Chung | ... | Hua Duan
  • Special Issue
  • - Volume 2018
  • - Article ID 2414609
  • - Review Article

A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma

Terrence D. Lewis | Minnie Malik | ... | William H. Catherino
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
Impact Factor2.276

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.